Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
about
Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature.Hematopoietic stem cell transplantation in infants.Primary atypical teratoid/rhabdoid tumor of central nervous system in children: a clinicopathological analysis and review of literature in China.Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with MedulloblastomaChildhood brain tumors: epidemiology, current management and future directions.Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children.Atypical teratoid rhabdoid tumor: current therapy and future directions.Molecular diagnostics in embryonal brain tumors.Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid TumorAtypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.Molecular diagnostics of CNS embryonal tumors.The clinical implications of medulloblastoma subgroups.Pediatric neuro-oncology: current status and future directions.Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience.Atypical teratoid rhabdoid tumor: long-term survival after chemoradiotherapy.Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).Atypical teratoid rhabdoid tumors of the posterior fossa in children.Long-term survival of an infant with an atypical teratoid/rhabdoid tumor following subtotal resection and low-cumulative dose chemotherapy: a case report.Rare Primary Central Nervous System Tumors Encountered in Pediatrics.Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.Atypical teratoid/rhabdoid tumors: the need for more active therapeutic measures in younger patients.Atypical teratoid/rhabdoid tumors in children treated with multimodal therapies: The necessity of upfront radiotherapy after surgery.Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies.
P2860
Q31028255-10F80F9A-A653-4D24-BECB-D134C1A0E5B9Q33418697-59006E10-30E8-4CC4-A450-D92F9D7EAFB8Q33802660-D6D744FC-5C66-4F8D-8B43-559F93C748D8Q33807896-CEC4F752-8CC9-4791-A63E-BBFE481835E6Q33970971-C92D510B-02A2-40B4-95FF-311CEE92F6DEQ34627709-365B975E-C4D4-4510-AE3E-4523F3103053Q35789013-F5E70A76-E478-4986-B01F-65D0E79CCC67Q36227670-A532C881-461B-4DCF-8826-49490E3E542EQ36619093-815CB78C-FE99-4709-9D0B-F1F076FE8CAFQ36893203-2407DC2E-3B9A-41AB-B099-7DF41DD155CEQ37367443-5B9747EB-0341-4E9E-833F-8743D56D5238Q37595251-CE863AB0-5C65-4F30-91CB-D778E061E1F4Q37794829-D27CA1CB-0766-4493-B79B-C8AA96DF3787Q38008153-97EDF351-7757-4B17-93D0-8924ABAC0675Q38035070-A7F2FF6E-4682-491A-B8B4-7B0B8212588CQ38121136-9683BB7C-3DCF-48E5-A764-3D5F69399DE0Q38383177-AF93C09E-057F-4984-8018-FC90E28AE44FQ38458080-5C02A7C3-B327-4AE4-8C94-498A86944A7AQ38678301-E633ED57-4008-477E-AFA0-DFFD159A605BQ40163705-84F31F43-47D2-450F-9717-549A8E8D7DE6Q40560695-CCFCFFDC-F0BF-4EF3-9DB4-C40AAF537F2CQ40989694-FD18CE62-917A-43D5-8F74-26B36186DC96Q41646521-8A652303-107E-499A-A945-DFCF67361BB7Q43606948-70FECBAE-E27B-480D-A2D5-570A4D36555BQ43715641-2862EE65-03F5-4160-8A48-B33DB846F683Q43944813-02FD9140-7CCA-446A-A28E-41EE85A03C2AQ44633685-77BF8943-8B1B-4C8E-9117-7FB55AC47F90Q47867664-D54495C2-65BB-4CCD-A668-3F0DF4F8A04DQ48743328-E3DBCA80-9124-4E6E-A06B-482F641F0EB0Q55102629-C96C968C-6E48-4C6E-94CB-D47FB1321FF2
P2860
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@en
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@nl
type
label
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@en
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@nl
prefLabel
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@en
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@nl
P2093
P50
P1476
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
@en
P2093
Adam Gassas
Annie Huang
Donald Mabbott
Laura Janzen
Michael Taylor
Tal Finkelstein-Shechter
P304
P356
10.1097/MPH.0B013E3181DCE1A2
P577
2010-07-01T00:00:00Z